Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

Multi-omics data integration by generative adversarial network

Multi-omics Data Integration Model Based on UMAP Embedding and Convolutional Neural Network

Heterogeneous graph attention network improves cancer multiomics integration

Multi-Omics Integration for Liver Cancer Using Regression Analysis

Comparative Analysis of Multi-Omics Integration Using Advanced Graph Neural Networks for Cancer Classification

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

AutoGGN: A Gene Graph Network AutoML Tool for Multi-Omics Research

A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction

Integrate Any Omics: Towards genome-wide data integration for patient stratification

Subtype-GAN: a deep learning approach for integrative cancer subtyping of multi-omics data

An Autoencoder and Generative Adversarial Networks Approach for Multi-Omics Data Imbalanced Class Handling and Classification

Spatial transformation of multi-omics data unlocks novel insights into cancer biology

MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis

An explainable graph neural network approach for effectively integrating multi-omics with prior knowledge to identify biomarkers from interacting biological domains

Integration of Multi-Omics Data for Gene Regulatory Network Inference and Application to Breast Cancer

Strategies to integrate multi-omics data for patient survival prediction

Progressively Helical Multi-Omics Data Fusion GCN and Its Application in Lung Adenocarcinoma

Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer

Gene regulatory network integration with multi-omics data enhances survival predictions in cancer

Interpretable meta-learning of multi-omics data for survival analysis and pathway enrichment